protein kinase cAMP-dependent type I regulatory subunit alpha
Last updated 10 Mar 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The PRKAR1A gene provides instructions for making one part (subunit) of an enzyme called protein kinase A. This enzyme promotes cell growth and division (proliferation). Protein kinase A is made up of four protein subunits. Two of these subunits are called regulatory subunits because they control whether this enzyme is turned on or off. The PRKAR1A gene provides instructions for making one of these regulatory subunits. Protein kinase A remains off when the regulatory subunits are attached to the other two subunits of the enzyme.
Video picks for GenesVideo library
Normal function
The PRKAR1A gene provides instructions for making one part (subunit) of an enzyme called protein kinase A. This enzyme promotes cell growth and division (proliferation). Protein kinase A is made up of four protein subunits. Two of these subunits are called regulatory subunits because they control whether this enzyme is turned on or off. The PRKAR1A gene provides instructions for making one of these regulatory subunits. Protein kinase A remains off when the regulatory subunits are attached to the other two subunits of the enzyme.
Conditions referring to this gene or chromosome
Other names
CAR
CNC1
PKR1
PRKAR1
Prkar1alpha
protein kinase A, RI-alpha subunit
protein kinase, cAMP-dependent, regulatory subunit type I alpha
protein kinase, cAMP-dependent, regulatory, type I, alpha
tissue-specific extinguisher 1
TSE1
Patient picks for Genes

Diabetes
MHRA approves teplizumab to delay progression of type 1 diabetes
Teplizumab (Tzield) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to help delay the onset of Stage 3 type 1 diabetes (T1D). Read on to see what this means if you are prescribed teplizumab and what it does for you.
by Lawrence Higgins

Healthy living
8 high-protein nuts to boost your strength
Packed with protein, delicious, easy to eat, and versatile - nuts are a great source of fuel for people building their fitness and strength. But not all nuts are created equal, which is why we count down the top eight nuts you should eat while strength training and serve these up with tasty recipe ideas.
by Lynn Stephen

Children's health
Alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency is an inherited genetic condition. A genetic condition is one that can be passed on from parents through genes. In alpha-1 antitrypsin deficiency the result of a genetic abnormality leads to lung and, in some people, liver damage. Lung symptoms are the most common and include shortness of breath, cough and wheezing. Symptoms can worsen over time. At present, there is no cure for alpha-1 antitrypsin deficiency. Treatment aims at slowing down the progression of the disease.
by Dr Philippa Vincent, MRCGP

Healthy living
Natural protein verses protein powder: which is better for strength training?
Consuming enough protein is essential for building strong muscles. Protein powder shakes are not a complete replacement for natural protein sources found in your food. However, you may consider supplementing your diet and strength-training regime with protein shakes. Before you decide if this is right for you, there are several benefits and considerations to take into account.
by Amberley Davis

Kidney and urinary tract
Proteinuria
Proteins are molecules that are found in almost every part of the body, including in the blood. The kidneys normally have a filter which stops protein from entering the urine, except in very tiny amounts; however, kidney problems can cause higher levels of protein to be found in the urine.
by Dr Doug McKechnie, MRCGP

Digestive health
Campylobacter
Campylobacter are germs (bacteria) that can cause food poisoning. Typically, food poisoning causes gastroenteritis, an infection of the gut (intestines), leading to diarrhoea and sometimes being sick (vomiting).
by Dr Colin Tidy, MRCGP
Related patient information and medicines

Patient information leaflet
Muscular dystrophy
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. If muscular dystrophy is suspected, tests can help to make an accurate diagnosis. There are.

Patient information leaflet
Primary liver cancer
Many types of cancer can spread to the liver - most commonly, cancers of the bowel Bowel cancer , pancreas Pancreatic cancer , stomach Stomach cancer , lung Lung cancer or breast Breast cancer. The behaviour, treatment and outlook of secondary liver cancers are often quite different to those of primary liver cancer. The rest of this leaflet is.

Patient information leaflet
Glycogen storage disorders
Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most people with a glycogen storage disorder respond well to.

Patient information leaflet
Liver function tests
What is a liver function test. Liver function tests are a type of blood test. A small amount of blood is taken from a vein in your arm. This involves using carbohydrates as your major source of calories, eating fat moder... Almost any pattern of liver function test abnormality can be caused by medicines (including over-the-counter medications), by.

Patient information leaflet
Cardiac enzymes
Cardiac enzymes are substances released by the heart muscle when it is injured - for example, during a heart attack or a severe case of angina. A heart attack (myocardial infarction) can present in many ways, the most common of which is chest pain. Before troponins, different blood tests were checked looking for heart muscle damage. This included.

Patient information leaflet
Duchenne muscular dystrophy
Duchenne muscular dystrophy is a condition which causes progressive muscle weakness. It starts in childhood and may be noticed when a child has difficulty standing up, climbing or running. It is a genetic condition and can be inherited. It usually affects only boys, although girls may carry the Duchenne gene. What causes Duchenne muscular.
Further reading and references
- protein kinase cAMP-dependent type I regulatory subunit alpha; MedlinePlus, National Library of Medicine.
- Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009 Jun;94(6):2085-91. doi: 10.1210/jc.2008-2333. Epub 2009 Mar 17.
- Horvath A, Bossis I, Giatzakis C, Levine E, Weinberg F, Meoli E, Robinson-White A, Siegel J, Soni P, Groussin L, Matyakhina L, Verma S, Remmers E, Nesterova M, Carney JA, Bertherat J, Stratakis CA. Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res. 2008 Jan 15;14(2):388-95. doi: 10.1158/1078-0432.CCR-07-1155.
- Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000 Sep;26(1):89-92. doi: 10.1038/79238.
- Kirschner LS. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex. J Intern Med. 2009 Jul;266(1):60-8. doi: 10.1111/j.1365-2796.2009.02114.x.
- Muhn F, Klopocki E, Graul-Neumann L, Uhrig S, Colley A, Castori M, Lankes E, Henn W, Gruber-Sedlmayr U, Seifert W, Horn D. Novel mutations of the PRKAR1A gene in patients with acrodysostosis. Clin Genet. 2013 Dec;84(6):531-8. doi: 10.1111/cge.12106. Epub 2013 Feb 21.
- Pereira AM, Hes FJ, Horvath A, Woortman S, Greene E, Bimpaki E, Alatsatianos A, Boikos S, Smit JW, Romijn JA, Nesterova M, Stratakis CA. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families. J Clin Endocrinol Metab. 2010 Jan;95(1):338-42. doi: 10.1210/jc.2009-0993. Epub 2009 Nov 13.
- Stratakis CA. Carney Complex. 2003 Feb 5 [updated 2023 Sep 21]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1286/
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

